MM+M Podcast 7.19.22: J&J’s Tylenol embraces ‘beyond the pill’

Adam Ricciardone, global head of self care R&D at Johnson & Johnson Consumer Health, discusses how Tylenol embraced a “beyond-the-pill” strategy.

MM+M Staff

July 19, 2022

12:00 pm

Adam Ricciardone, global head of self care R&D at Johnson & Johnson Consumer Health, discusses how 70-year-old Tylenol embraced a “beyond-the-pill” strategy, as well as how it fits in the context of the pharma industry’s overall shift toward promoting self-care.

From Our Partners

The health data ‘dream state’

Partner Content

The health data ‘dream state’

How condition-specific audience segments can lift your brand beyond traditional targeting.

Mapping the identity experience in digital health communications

Partner Content

Mapping the identity experience in digital health communications

How IX offers greater nuance in engaging with audiences.

The state of DE&I: Moving the needle from commitment to progress

Partner Content

The state of DE&I: Moving the needle from commitment to progress

Employees and consumers alike expect companies to take meaningful steps toward creating a more equitable and inclusive future. As shown by the findings from MM+M’s 2022 Diversity Survey, conducted in partnership with IPG Health, progress has been made but we still have a long way to go in the healthcare industry.

How to keep digital pharma marketing relevant in the times of global crises

Partner Content

How to keep digital pharma marketing relevant in the times of global crises

Nataliya Andreychuk, CEO of Viseven, discusses digital marketing trends and more during her chat with Marc Iskowitz, editor-at-large, MM+M.